SergeY Chebotarev

Mr. SergeY Chebotarev

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2024 in Biomimetics
Verified
Journal Article
Open access
PDF file
АKАльбина Kondratenko
Альбина Kondratenko
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
DVDaniil Volov
Daniil Volov
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
VCVladimir E. Chernov
Vladimir E. Chernov
VSVictor I. Sevastianov
Victor I. Sevastianov
The umbilical cord is a material that enhances regeneration and is devoid of age-related changes in the extracellular matrix (ECM). The aim of this work was to develop a biodegradable scaffold from a decellularized human umbilical cord (UC-scaffold) to heal full-thickness wounds. Decellularization was performed with 0.05% sodium dodecyl sulfate solution. The UC-scaffold was studied using morphological analysis methods. The composition of the UC-scaffold was studied using immunoblotting and Fourier transform infrared spectroscopy. The adhesion and proliferation of mesenchymal stromal cells were investigated using the LIVE/DEAD assay. The local reaction was determined by subcutaneous implantation in mice (n = 60). A model of a full-thickness skin wound in mice (n = 64) was used to assess the biological activity of the UC-scaffold. The proposed decellularization method showed its effectiveness in the umbilical cord, as it removed cells and retained a porous structure, type I and type IV collagen, TGF-β3, VEGF, and fibronectin in the ECM. The biodegradation of the UC-scaffold in the presence of collagenase, its stability during incubation in hyaluronidase solution, and its ability to swell by 1617 ± 120% were demonstrated. Subcutaneous scaffold implantation in mice showed gradual resorption of the product in vivo without the formation of a dense connective tissue capsule. Epithelialization of the wound occurred completely in contrast to the controls. All of these data suggest a potential for the use of the UC-scaffold.

15 December 2021 in Pediatric Traumatology, Orthopaedics and Reconstructive Surgery
Verified
Journal Article
Open access
PDF file
SCSergeY Chebotarev
SergeY Chebotarev
VKVladimir V. Khominets
Vladimir V. Khominets
DZDmitry A. Zemlyanoy
Dmitry A. Zemlyanoy
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
AGAleksej S. Grankin
Aleksej S. Grankin
КИКалюжная Лидия Ивановна
Калюжная Лидия Ивановна
BACKGROUND: The treatment of traumatic and degenerative cartilage damage is one of the largest areas in orthopedic practice, and the therapy success remains limited. AIM: To analyze the results of surgical treatment of patients with traumatic and degenerative injuries of the knee joint hyaline cartilage using debridement and osteoperforative techniques, taking into account the time from the surgical intervention. MATERIALS AND METHODS: A statistical analysis was conducted on the treatment outcomes of servicemen with traumatic and degenerative damage in the knee joint articular hyaline cartilage. Patients underwent surgical treatment using osteoperforative techniques (abrasive chondroplasty, tunneling, and microfracturing) at the Clinic of Military Traumatology and Orthopedics of the S.M. Kirov Military Medical Academy from 2009 to 2019. The study relied on the data obtained from questioning the patients using the Knee Injury and Osteoarthritis Outcome Score (KOOS) and LKSS questionnaires. RESULTS: The result analyses using the KOOS and LKSS scales revealed significantly higher good results in the observed group in the postoperative period from 1 to 4 years than in the groups from 4 to 8 and more than 8 years (p = 0.004). No significant differences were determined in the treatment outcomes of the groups with resection and different osteoperforative methods. CONCLUSIONS: Treatment methods for hyaline cartilage defects, such as resection and osteoperforative, are technically simple with good treatment outcomes in patients with articular cartilage injuries from 1 to 4 years postoperative. Treatment outcome deterioration was noted in 48 years postoperative, regardless of the treatment method used, which is more significant in patients in 8 years postoperative.

7 March 2026 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
SCSergeY Chebotarev
SergeY Chebotarev
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
MKM. E. Kotova
M. E. Kotova
АKАльбина Kondratenko
Альбина Kondratenko
VSV. V. Salukhov
V. V. Salukhov
Non-healing ulcers pose a serious problem for public health due to the high cost of treatment, prolonged disability of patients, and low efficacy of therapy. They are the leading cause of non-traumatic lower limb amputations. The development of innovative bioengineering products is a significant step in the treatment of non-healing diabetic foot ulcers. One such product is a tissue-engineered acellular product made from highly regenerative human umbilical cord biomaterial. It contains growth factors, cytokines, and components of the extracellular matrix of Wharton’s jelly, which accelerates wound healing. THE AIM of this clinical study is to evaluate the safety and efficacy of a tissue-engineered acellular product from Wharton’s jelly of the umbilical cord for the treatment of chronic non-healing lower limb ulcers in patients with diabetic foot syndrome. RESULTS: a 60-year-old woman diagnosed with type 2 diabetes mellitus had chronic ulcers that had not responded to standard treatment for more than a year and a half. She was observed for 4 weeks in August 2024. As a result of the local application of an acellular product from human umbilical cord, signs of reduction in wound size and their complete healing were noted 4 weeks after the start of observation. CONCLUSION: clinical observation has demonstrated the safety and efficacy of the acellular product from human umbilical cord for the treatment of chronic non-healing ulcers of diabetic origin.